Table 2.

Serial galectin-3 levels and risk of CV mortality and new-onset HF

Model	New-onset HF (95% CI)	P	Cardiovascular mortality (95% CI)	P
Unadjusted
Not persistently elevated	1.00		1.00
Persistently elevated	4.10 [2.64–6.34]	<0.001	5.66 [3.07–10.43]	<0.001
Age and gender adjusted
Not persistently elevated	1.00		1.00
Persistently elevated	1.95 [1.22–3.13]	0.006	2.43 [1.29–4.59]	0.006
Multivariable full adjustment*
Not persistently elevated	1.00		1.00
Persistently elevated	1.85 [1.10–3.13]	0.02	1.65 [0.76–3.56]	0.20

^*Adjusted for age, sex, smoking, diabetes mellitus type 2, history of myocardial infarction or stroke, hypertension, hypercholesterolemia, waist-hip-ratio, BMI, systolic blood pressure, diastolic blood pressure, triglycerides, glucose, estimated GFR, urinary albumin excretion, CRP, NT-proBNP.